Clinical trials on the Alfred precinct have received a funding boost this week, with four Monash researchers receiving a total of $13.6 million in the latest round of the NHMRC Clinical Trials and Cohort Studies Scheme. These trials will enable further research into treatments for debilitating conditions such as diabetes and epilepsy, as well as critical health issues including antimicrobial resistance and intensive care. Congratulations to our researchers!
More than $19.7 million awarded to Monash researchers for vital medical research
The National Health and Medical Research Council (NHMRC) has announced more than $19.7 M in funding for Monash research projects that incorporate diabetes, epilepsy and seizures, infection management, alcohol treatment, acidic blood trial and a new device to deliver treatment to premature babies.
Monash University – Central Clinical School
Clinical trials funding for epilepsy, diabetic renal disease and surgical infection
Central Clinical School’s excellence in clinical trials has been recognised once again with three of our researchers successful in the latest round of the NHMRC Clinical Trials and Cohort Studies Scheme funding, announced on 24 May.
Vaccinated immune system response to new SARS-COV-2 variants
Associate Professor Menno van Zelm was invited by the prestigious journal Science Immunology to write a commentary on two papers that deal with immune memory after vaccination and recognition of Omicron variants of SARS-CoV-2.
Dietary fibre in gut may help with skin allergies: Monash study
A Monash University study exploring the emerging gut-skin axis has found that microbial fermentation of dietary fibre in the gut can protect against allergic skin disease. The research could potentially lead to novel treatments to prevent or treat allergies.
Advancing new therapeutic targets for people with drug-resistant epilepsy
To make significant research advances to improve outcomes for people with drug-resistant epilepsy, researchers need to understand the molecular and neurobiological processes that occur within the brain to enable them to identify new therapeutic targets.
CaRE webinar video featuring dementia researchers and advocates now published
The Community and Researcher Engagement (CaRE) committee hosted a webinar on 18 May 2022, “What we know about the brain and how it changes with dementia”, which covered a range of relevant topics and perspectives relating to dementia, from the perspectives of those affected by the disease, clinicians, and researchers.
Urgent healthcare needs continued to present to hospital during lockdowns
While there were many anecdotal reports of reduced care-seeking behaviour during 2020 Melbourne lockdowns, analysis suggests that those with the most urgent healthcare needs continued to present to hospital.
Congratulations to Arwel Jones and Narelle Cox on Lung Foundation Australia grants
Congratulations to Dr Arwel Jones and Dr Narelle Cox in the Department of Respiratory [email protected], Monash University, who have both won Lung Foundation Australia (LFA) grants.
On your back? Side? Face-down? Mice show how we sleep may trigger or protect our brain from diseases like ALS
Associate Professor David Wright’s new research looked at how the glymphatic system, which removes waste from the brain during sleep, could prevent ALS.
Monash University – School of Public Health and Preventive Medicine
Registry shows difference in myeloma outcomes for Maori and Pacific People in New Zealand
A new paper from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR) has highlighted concerning differences between Maori and Pacific People (MPP) with myeloma and other New Zealanders with the same blood cancer.
Return to work a culture change
Burnet Institute shares the challenge faced by many businesses of how best to manage the return to work on-site of staff and students accustomed to working from home.